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C. elegans maximum velocity correlates with
healthspan and is maintained in worms
with an insulin receptor mutation
Jeong-Hoon Hahm1, Sunhee Kim1,*, Race DiLoreto2,*, Cheng Shi2,*, Seung-Jae V. Lee3,
Coleen T. Murphy2 & Hong Gil Nam1,4
Ageing is marked by physical decline. Caenorhabditis elegans is a valuable model for identifying
genetic regulatory mechanisms of ageing and longevity. Here we report a simple method to
assess C. elegans’ maximum physical ability based on the worms’ maximum movement
velocity. We show maximum velocity declines with age, correlates well with longevity,
accurately reports movement ability and, if measured in mid-adulthood, is predictive of
maximal lifespan. Contrary to recent ﬁndings, we observe that maximum velocity of worm
with mutations in daf-2(e1370) insulin/IGF-1 signalling scales with lifespan. Because of
increased odorant receptor expression, daf-2(e1370) mutants prefer food over exploration,
causing previous on-food motility assays to underestimate movement ability and, thus, worm
health. Finally, a disease-burden analysis of published data reveals that the daf-2(e1370)
mutation improves quality of life, and therefore combines lifespan extension with various
signs of an increased healthspan.
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A
geing is an important risk factor for disease and is
accompanied by the decline of many physiological
characteristics, including physical performance, negatively
affecting quality of life. Therefore, quality of life with age, not just
longevity, is important for our ageing society. Caenorhabditis
elegans has been a valuable model organism in revealing the
genetic regulatory mechanisms of ageing and longevity1,2. One of
the best-studied longevity pathways is the insulin/IGF-1
signalling (IIS) pathway, which regulates longevity in response
to nutrient levels through its control of the activity of the FOXO
transcription factor and its downstream targets3–6. Mutations of
the DAF-2 insulin receptor, particularly the canonical allele
daf-2(e1370), double lifespan3 and extend the abilities to learn
and remember, resist stress and infection, repair axons7, and
suppress neuronal morphological defects8–10 with age. The
components of the IIS pathway are well-conserved, and are
linked to extreme longevity in humans11 as well. Recently, despite
the fact that the daf-2 mutation extends many physiological
functions with age7–10, Bansal et al. concluded that daf-2(e1370)
IIS mutants are less healthy than wild-type animals, dis-
proportionately extending their ‘unhealthy’ lifetime2,12.
One of the most powerful tests of physical ability in elderly
humans is the short physical performance battery (SPPB)13, an
assessment of the maximum exercise capacity of lower extremities
over a short period of time. The SPPB accurately predicts risk of
disability14, length of hospital stay, and mortality over the year
after hospital discharge15. The SPPB includes a short (4m) walk
to measure maximum gait speed. Like humans, C. elegans shows
age-related decline in physical ability, which is manifested by
reduced body movement16–22. We wondered whether a similar
metric of maximum velocity (MV) in a short period (30 s) would
be equally informative in C. elegans. We found that worms’ MV
declines with age, correlates well with longevity, accurately
reports movement ability, and importantly, is predictive of future
longevity. daf-2(e1370) mutations extend MV and ‘healthspan’,
scaling with lifespan19. Motility assays performed on bacteria
underestimate daf-2(e1370) mutants’ movement ability due to
their high odr-10 levels and subsequent preference for food over
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Figure 1 | MV is correlated with longevity. (a) Age-dependent changes in the MVof 52 individual wild-type worms. Black dots represent the average value
at each age. (b,c) Correlation between MVand lifespan (b) and correlation between mean velocity and lifespan (c) of individual worms. The MVs and mean
velocities of individual worms were measured at day 9 of adulthood and their lifespans were measured thereafter. r2, coefﬁcient of determination. n¼ 173.
(d) Survival curves of the low-MV (n¼89) and high-MV (n¼84) group worms. The groups were divided at day 9 of adulthood (grey dotted line) and the
survivorship of worms in each group was measured thereafter. (e) Correlation of MV with mitochondrial morphology at day 9 of adulthood. Scores of
mitochondrial morphology of low-MV and high-MV groups were 1.3±0.5 and 2.5±0.5, respectively (n¼ 27). The bottom and top of the box and whiskers
are the ﬁrst and third quartiles, and the band inside the box is the average. Signiﬁcance was determined using a two-tailed, unpaired t-test. ****Po0.0001.
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exploration. We used human disease-burden models to assess
C. elegans mutants’ quality of life; quality-adjusted reanalysis
of data from previously published healthspan studies2,19
demonstrates that daf-2(e1370) mutants’ healthspan correlates
with longevity extension, and in terms of disease-burden analysis,
improves quality of life. The IIS pathway mutation daf-2(e1370)
coordinates the extension of lifespan with many aspects of
healthspan, providing valuable insight into mechanisms that
extend functional health with age.
Results
MV correlates with lifespan. To mimic the SPPB test used to
assess health in elderly humans, we measured worms’ MV over
30 s on an unseeded nematode growth medium (NGM) plate each
day of adulthood (Supplementary Fig. 1). Our assay differs from
previous motility assays in its brevity (30 s versus 5min (ref. 21)
or longer23), longitudinal testing of individual worms rather than
populations, and measurement on plates without bacteria2. MV
appears to not simply be a response to harsh touch, as harsh-
touch mutants behave like wild-type worms in the assay, and the
MV is distributed over the entire 30 s window for all animals
(Supplementary Fig. 2).
To assess age-associated decline of physical performance, we
measured MV of 52 individual wild-type worms each day of their
lifespan (Fig. 1a). We found that motility decreased with age
(Supplementary Fig. 3), with MV declining earlier and more
drastically than mean velocity (Supplementary Fig. 3). During the
early phase of adulthood (day 1–5), MV of individual worms was
maintained in the range of 0.22–0.52mm s 1. However, from
day 6 onwards, all worms showed a decline in MV with age.
We grouped worms into high (Z0.22mm s 1) and low
(r0.21mm s 1) MVs; the criterion was based on the minimum
MV at day 1 of adulthood. The population of the low-MV group
increased almost exponentially, reaching 54.6% by day 9 of
adulthood (Supplementary Fig. 4). We then examined the
correlation between MV of worms at day 9 of adulthood
(midlife) and their lifespan thereafter. Day 9 MV correlated well
with lifespan (coefﬁcient of determination (r2)¼ 0.71), better
than the correlation between lifespan and mean velocity
(r2¼ 0.44; Fig. 1b,c), thrashing rate (r2¼ 0.18; Supplementary
Fig. 5), or pharyngeal pumping (r2¼ 0.65; Supplementary Fig. 5).
Remarkably, the median lifespan of worms in the day 9 high-MV
group (23±3.2 days) was 35.3% longer than that of the worms in
the day 9 low-MV group (17±3.6 days; Fig. 1d). Thus, MV of
wild-type worms at day 9 of adulthood is a reliable predictor of
longevity thereafter.
In humans, mitochondrial defects are associated with ageing of
skeletal muscle and are correlated with reduced physical strength
in the elderly24–26. Young C. elegans’ mitochondria are tubular27;
however, gradual fragmentation with age results in sparse,
globular mitochondria (Supplementary Fig. 6). At day 9 of
adulthood, worms in the low-MV range had very fragmented
mitochondria, while the high-MV range group’s mitochondria
were signiﬁcantly less damaged at the same age (Fig. 1e and
Supplementary Fig. 7). In addition, expression of the protective
lifespan biomarker sod-3 (ref. 28) was 1.7-fold higher in the high-
MV group than in the low-MV group (Supplementary Fig. 8).
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Figure 2 | Correlation of MV with lifespan in daf-2 mutants. (a) Age-associated change of survivorship in N2 (wild type) (n¼ 52), daf-2(e1370) (n¼ 32)
and daf-16(mu86) (n¼42) worms. (b,c) Age-associated change of MVs in daf-2 (b) and daf-16 mutant worms (c). (d) Age-associated change of average
MVs in N2 (n¼ 52), daf-2 (n¼ 32) and daf-16 (n¼42) mutant worms. Error bars represent s.d. (e) A cumulative difference in physical performance in N2
and daf-16 and daf-2 mutant worms as indicated by area under curves in d. The relative values of area under curves are 1.0±0.2, 0.9±0.2 and 2.4±0.4 for
N2, daf-16 and daf-2 worms, respectively. (f) Comparison of healthspan and gerospan in N2, daf-16 and daf-2 worms. Healthspan was deﬁned as ‘the period
during which the worm showed 450% maximal functional capacity of wild type’2. Gerospan was deﬁned as ‘the period during which the worm showed
o50% maximal functional capacity of wild type’2. (g) The healthspan-to-gerospan ratio normalized to their maximal lifespan in N2, daf-16 and daf-2
worms.
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These data show that MV correlates with two age-associated
physiological parameters, and suggest that mechanisms
determining MV might also regulate mitochondrial integrity
maintenance and stress protection gene expression.
daf-2(e1370) mutation extends healthspan. We next assessed the
MV of long-lived daf-2(e1370) insulin/IGF-1 receptor mutants
and short-lived mutants of the DAF-16 FOXO transcription factor
(daf-16(mu86)), which is required for daf-2 mutants’ long-
evity3,4,29 (Fig. 2a). daf-2 animals exhibited a higher MV with age,
particularly from day 10 onwards (Fig. 2b–d). At day 26 of
adulthood, when all the wild-type worms had died, daf-2 mutants
still maintained on average 36% of MV (Fig. 2d). We examined
the correlation of MV on each day with the lifespan for the worms
in the longitudinally tracked cohort (Figs 1a and 2b,c). The
correlation between MV and lifespan is best on day 9 for N2
worms, day 23 for daf-2 and day 10 for daf-16 (Supplementary
Fig. 9); in all cases, the best correlation between MV and lifespan
occurs within 1 day of the ﬁrst death in the cohort. We integrated
the area under the MV curve to serve as an indicator of overall
physical performance; daf-2 mutants showed a 2.4-fold increase
over wild type, and daf-16 mutants showed slightly lower physical
performance (Fig. 2e). Thus, daf-2(e1370) mutation extends
physical ability with age.
We then used MV to determine the ‘healthspan’ (deﬁned as the
period with 450% of maximal activity2) and ‘gerospan’ (period
with o50% maximal activity2) ratios of wild-type, daf-16(mu86),
and daf-2(e1370) mutant worms, in the same manner as
Bansal et al.2. While this type of analysis does not include any
error calculation, our results suggest that daf-2 mutants increased
healthspan more than twofold compared with wild-type and daf-16
mutants (Fig. 2f), and the resulting normalized healthspan-to-
gerospan ratios were similar among the three strains (Fig. 2g).
Thus, daf-2(e1370) mutation extends both lifespan and healthspan
to a similar extent, without proportionally extending the unhealthy
part of life, in contrast to Bansal et al.2 conclusions.
odr-10 levels determine on-food motility rates. We were con-
cerned that differences in motility assays may have led to dis-
crepancies with the previous report2. Our assay measures MV on
plates without bacteria, while Bansal et al.2 measured the distance
worms moved on bacteria. We wondered whether daf-2’s lower
motility on food might not reﬂect its ability to move, but rather
its preference for food over exploration. Food-seeking preference
is determined by levels of the odorant receptor odr-10 (ref. 30);
high levels of odr-10 suppress food-exploration behaviour30.
Ryan et al.30 showed that odr-10, despite the fact that it is only
expressed in the AWA neurons and primarily detects diacetyl,
plays a major role in food detection and is the primary factor in
determining the decision of males to explore (mate search) rather
than feed. Indeed, we found that the expression of odr-10,
which contains a DAF-16-binding element 809 bp upstream
of its start site, is elevated 15–20-fold in daf-2(e1370) mutants
(Fig. 3a). Furthermore, we observed that reduction of odr-10
levels dramatically increases daf-2’s motility on bacteria: unlike
control-treated animals, which stop moving after 1.5–3min when
placed onto bacteria, daf-2(e1370);odr-10(RNAi) worms continue
to move constantly over a 10min assay period (Fig. 3b), and
reduction of wild-type worms’ odr-10 levels has no signiﬁcant
effect (Fig. 3c and Supplementary Movies 1–3). (Interestingly,
knockdown of other genes involved in odour detection, including
odr-3, odr-7 and osm-9, did not have the same effect on
daf-2(e1370) motility (Supplementary Fig. 10).) Therefore,
motility can only be measured accurately off food, because
movement on bacteria measures food-seeking rather than ability
to move.
daf-2(e1370) mutation increases quality of life. As MV is only
one metric of healthspan, we reanalysed the entire Bansal et al.2
healthspan data set. (The same daf-2 allele, e1370, was used in
their studies, as well.) In our analysis, we normalized each health
metric at each time point to the maximum score of wild type to
directly compare performance levels (Fig. 4a). This reanalysis
shows that daf-2 mutants were healthier than wild type in all
metrics except thrashing in liquid. However, previous thrashing
measurements of daf-2 mutants31 and another long-lived IIS
mutant, age-1 (ref. 32), demonstrate that these IIS mutants
maintain thrashing activity with age better than wild type.
We wondered whether cost-utility (disease burden) methods
developed to assess quality of life33 (which are typically used to
make cost assessments of human disease treatment options)
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could be applied to these healthspan analyses of C. elegans.
To do so, we combined information from the lifespan curve and
health measurements reported by Bansal et al. to obtain a
‘quality-adjusted lifespan’ curve, according to the method of
Zeckhauser and Shepard33. We multiplied the lifespan curve by
the normalized healthspan curve, producing a curve that
describes both the declining health of the animal and the
declining survival of the population (Fig. 4b). By calculating the
area under the curve (AUC) of the quality-adjusted lifespan, we
can visualize total quality of life, taking into account both survival
and health (Fig. 4c; Methods section). Reanalysis of the Bansal
et al.2 data using this approach suggests that while not all
longevity mutants have a commensurate increase in life quality
(in fact, some longevity mutants, such as clk-1, exhibit lower total
quality, as Bansal et al. reported), increased health and extended
lifespan result in a higher total quality for daf-2(e1370) mutants.
(We note that the cumulative quality-adjusted score for thrashing
is equivalent for daf-2(e1370) and wild type, but that thrashing
has little correlation overall with longevity (Supplementary
Fig. 5).) We reached a similar conclusion upon reanalysis of the
data from Huang et al.19, which also measured several healthspan
parameters (Fig. 4d and Supplementary Fig. 11a,b). In addition,
applying this analysis to our own MV data shows the same
dramatic increase in daf-2(e1370) lifespan quality (Supplementary
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Fig. 11c–e). Thus it appears from multiple analyses of healthspan
that daf-2(e1370) mutants have a higher quality of life than wild-
type worms.
Discussion
Here we have modelled the SPPB assessment of physical ability in
elderly humans in worms, using a simple assay of C. elegans’
maximum ability to move over a short period. MV correlates well
with age; in fact, MV performance at midlife (day 9) can predict
the remaining lifespan of the individual. Our analysis also reveals
that other widely used healthspan metrics are less correlated with
lifespan; thrashing is a particularly poor correlate (r2¼ 0.18),
while pumping has a good correlation (r2¼ 0.65) but shows
highly irregular patterns (Supplementary Fig. 5). Thus, MV is a
powerful healthspan proxy and may be the most informative
metric of C. elegans’ health with age.
An unexpected beneﬁt of this experimental design is that it is
not confounded by the worms’ ongoing assessment of its bacterial
food source. We discovered that daf-2 has an inherently higher
preference for food than exploration, likely due to its increased
expression level of the daf-2/daf-16 target odr-10; high levels of
the ODR-10 odour receptor cause daf-2 worms to prefer food
over exploration, slowing its movement on bacteria. (Further, our
data on other chemosensory genes suggest that odr-10 is a
particularly good indicator of food preference.) As this type of
movement is not limited by ability, but rather by preference, it
may be difﬁcult to draw conclusions regarding healthspan from
on-food motility assays.
Measurements that take into account both lifespan and
healthiness are important in assessing quality of life with age,
and the clinical implications of coordinated extension of lifespan
and healthspan are immense. Not all lifespan interventions will
improve health or total quality, as clk-1 mutants demonstrate. In
fact, several longevity mutants are less healthy overall than
wild-type worms by different measurements, and it is important
to note which mutants may have a long life with no health
beneﬁt. However, we ﬁnd no evidence to support the claim by
Bansal et al. that daf-2(e1370) mutants spend a greater fraction of
life in a frail state; in fact, daf-2 mutants demonstrate that
healthspan and lifespan can be coordinately extended. From the
analysis of our own data and that of published experiments, it
seems clear that daf-2 extends not only lifespan, but also many
abilities with age. In addition to the standard C. elegans-speciﬁc
‘healthspan’ assays (heat stress, oxidative stress and movement),
daf-2 extends behaviours that are relevant for human decline with
age, as well. This includes the abilities to learn and remember34,
repair axons7, resist pathogenic infections35, suppress age-related
neuronal morphological defects8–10 and neurodegenerative
protein aggregation36, maintain neuromuscular junction
activity23,37, and maintain high-quality oocytes with age38.
Many of the downstream targets of the daf-2 insulin signalling
pathway6 that enable these functions have been identiﬁed, and
many of these genes and the underlying mechanisms are
conserved in mammals; therefore, the extended abilities that
daf-2 exhibits offers therapeutic target possibilities.
Deﬁning ‘healthspan’ and ‘gerospan’ based on population
maximum lifespans ignores the fact that quality is a continuum.
Instead, our analysis takes into account the length of time an
individual can expect to live, and how healthy that individual can
expect to be with age. In the case of daf-2(e1370) mutants, quality
of life is clearly superior. The mechanistic study of coordinated
health and life extension might allow the development of
therapeutics to remedy end-of-life problems or to compress
morbidity, decreasing health costs. C. elegans IIS longevity
mutants remain valuable tools in understanding the mechanisms
by which we might achieve these goals.
Methods
Strains. The C. elegans strain, N2 Bristol, was used as the wild type. The N2
strain and the insulin/IGF-1 mutants, daf-2(e1370), daf-16(mu86), CF1553
muIs84[pAD76 (sod-3::GFP)] and PD4251 ccIs4251 I; dpy-20(e1282) IV were
obtained from the Caenorhabditis Genetics Center.
Measurement of worm MV. Synchronized worms were prepared by placing adult
worms on a NGM plate and allowing them to lay eggs for 3 h. After removing the
adult worms, each synchronized progeny was transferred to a single NGM plate
and cultured to L4 stage. After 24 h, single worms were transferred to the physical
assay plate and movements were recorded immediately. The assay conditions were
as follows: 20 C and B40% humidity, with no lid. The physical assay plate was
prepared in the same manner as the NGM, but with no bacterial lawn. The
recording system comprised a stereomicroscope (Nikon SMZ 745T), a charge-
coupled device camera (TUCSEN TCH-5.0) and imaging software (TUCSEN
ISCapture). A  12.14 zoom lens was used to keep the worms within the ﬁeld of
view. Movement was recorded every 24 h throughout the lifespan of each worm.
The recording period was 30 s at a rate of 30 frames per second. After recording,
the worm was transferred to a fresh NGM plate (the ‘growth plate’ shown in
Supplementary Fig. 1). The locomotion velocity was expressed as mm per second
(the distance (mm) between displaced centroids per second). Recorded images
were analysed by ImageJ and wrMTrck (plugin for ImageJ: www.phage.dk/plugins).
The locomotion velocity data were imported into an Excel spreadsheet. The peak
locomotion velocity observed in the 30 s period was used as the MV.
Lifespan analysis. Lifespan was assessed on NGM plates at 20 C. The number of
live animals was scored every day until death. Lifespan was analysed by Oasis
survival analysis software39.
Pharyngeal pumping and thrashing rate decline assays. Synchronized single
worms were observed every day. The number of contractions in the terminal bulb
of pharynx was counted for 30 s (n¼ 19). The change in the reciprocating motion
of bending at the mid-body in S-basal medium was counted as a body bend. The
number of body bends was counted for 30 s (n¼ 20).
Qualitative analysis of mitochondrial morphology. Morphological categories
were deﬁned according to Regmi et al.27: (1) images showing a majority of long
interconnected mitochondrial networks were classiﬁed as tubular; (2) images
showing a combination of interconnected mitochondrial networks along with some
smaller fragmented mitochondria were classiﬁed as intermediate; (3) images
showing a majority of short mitochondria were classiﬁed as fragmented; and
(4) images showing sparse globular mitochondria were classiﬁed as very fragmented.
We scored mitochondrial morphology as ‘1’ (very fragmented), ‘2’ (fragmented),
‘3’ (intermediate) and ‘4’ (tubular; Supplementary Fig. 7). Mitochondrial morpho-
logy was examined in PD4251 strains at day 9 of adulthood after MV was recorded.
Worms were immobilized during imaging using 30mM sodium azide. Imaging was
performed using a microscope equipped with a C-Apochromat 40x/1.20W Korr FCS
M27 and a photo-multiplier tube. Zen 2011software (black edition) was used to
acquire ﬂuorescent z stacks of individual animals (1mm per slice).
Observation of sod-3 expression. sod-3 expression was examined in CF1553
strain worms at day 9 of adulthood after MV was recorded. Imaging was performed
using a microscope equipped with a C-Apochromat 10x/1.20W Korr FCS M27
and a photo-multiplier tube. Zen 2011software (black edition) was used to
acquire ﬂuorescent z stacks of individual animals (1 mm per slice). Worms were
immobilized during imaging using 30mM sodium azide.
odr-10 qRT-PCR measurements. Two sets of primers (#1 and #2) were used to
measure the expression of odr-10 by quantitative reverse transcription PCR
(qRT-PCR) in N2 and daf-2 mutants. For each primer set, odr-10 expression in
wild type was normalized to 1. pmp-3 was used as a reference gene.
‘odr-10-qRT-1-r’ 50-AACGGTGCGATGAACATGAC-30
‘odr-10-qRT-1-f’ 50-CTTCAGGTATCCCGATCTGAAACT-30
‘odr-10-qRT-2-r’ 50-TCAGATCGGGATACCTGAAGA-30
‘odr-10-qRT-2-f’ 50-TCTACTGCGGATATGCCACG-30
Reference gene primers: pmp-3
Forward: 50-AGTTCCGGTTGGATTGGTCC-30
Reverse: 50-CCAGCACGATAGAAGGCGAT-30
Quality-adjusted lifespan analysis. Quality metrics were taken from published
work. Because the raw data from Bansal et al.2 were not made publicly available by
the authors at time of submission of this paper, we extracted data from their ﬁgures
using GetData Graph Digitizer. (No N or error information is available, however.)
The lifespan (L(t)) (% surviving with age) and healthspan (H(t)) (health
measurement with age) data were graphed using a left-hand step function. The
curves were combined by multiplying the lifespan and healthspan curves together,
with the value of the resulting quality-adjusted lifespan curve (Q(t)) being
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Q(t)¼ L(t)H(t). The AUCs was calculated by taking the deﬁnite integral of this
step function. The set of timepoints T is zero-indexed and consists of
T¼ {t0,t1,y,tn}, and we calculate the AUC as shown in equation (1).
AUC ¼
Xn
i¼1
Q tið Þ ti  ti 1ð Þ ð1Þ
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